Introduction: As the development of new antimicrobial agents faces a historical decline, the
issue of bacterial drug resistance has become a serious dilemma that threatens the human …

Antimicrobial drugs resistant microbes have been observed worldwide and therefore
alternative development of antimicrobial peptides has gained interest in human healthcare …

Infection sustained by multidrug‐resistant and extensively drug‐resistant bacterial
pathogens is often untreatable with the standard of care antibiotics, and the combination of …

The continued use of antibiotics has been accompanied by the rapid emergence and spread
of antibiotic-resistant strains of bacteria. Antimicrobial peptides (AMPs), also known as host …

Antimicrobial peptides (AMPs) are widespread in multicellular organisms. These structurally
diverse molecules are produced as the first line of defense against pathogens such as …

Background: Managing bacterial infections caused by multidrug-resistant (MDR) and
biofilmforming bacteria is a global health concern. Therefore, enormous efforts were directed …

To address the growing resistance of Gram‐negative bacteria and enhance the clinical
application potential of antimicrobial peptides. In this study, we combined two α‐helical …

Background Antimicrobial peptides are promising alternatives to antibiotics to treat bacterial
and fungal infections, especially drug-resistant clinical pathogens. Methods Antimicrobial …

Antimicrobial peptides (AMPs) are endogenous polypeptides produced by multicellular
organisms in order to protect a host from pathogenic microbes. AMPs are also defined as …

Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the
treatment of antibiotic-resistant bacterial infections. The present study investigates the …